Tirzepatide: The New Weight Loss Medication Seeing Remarkable Results

By now, you’ve probably seen the craze caused by Semaglutide – also known as Ozempic – the diabetic medication approved for weight loss. However, there is a new peptide creating quite a buzz by helping adults achieve up to 15.7% weight loss weight in a recent study.

Introducing Tirzepatide – the generic version of Mounjaro – could be the answer to your difficulty with losing weight. Now offered at Forum Health Akron!

What is Tirzepatide?

Tirzepatide is an injectable peptide medication approved to help Type 2 diabetics control blood sugar. It mimics the hormones GIP and GLP-1 critical for regulating appetite, modulating fat utilization and decreasing food intake overall. The medication has received FDA Fast Track designation to speed up its application for weight loss; however, doctors are using it off-label in medical weight loss programs.

How does Tirzepatide help you lose weight?

  • Tirzepatide mimics the action of two different gut hormones – GIP and GLP-1 to help:
  • Lower blood sugar
  • Slow down the movement of food from the stomach
  • Regulate appetite
  • Modulate the utilization of fat
  • Make you feel fuller for longer

Is Tirzepatide different from Semaglutide?

Both peptides work in similar but different ways. They’re in a class of medications known as GLP-1 agonists meaning that they mimic the hormone GLP-1 which is involved in blood sugar control and digestion.

Tirzepatide, however, mimics a second hormone called GIP, which plays a vital part in targeting receptors to inhibit caloric intake and stimulate satiety in the hypothalamus to give a sensation of fullness. With GLP-1 and GIP working together, Tirzepatide may offer patients greater blood glucose control and weight loss results.

What results can I expect on Tirzepatide?

You may start feeling the effects after your first dose and should begin experiencing weight loss within the first two weeks of your program. However, everyone’s weight loss journey is different and how much weight you have to lose will determine the duration of your program. However, once you reach your target dose you will see the most amount of weight loss.

recent clinical study showed the use of Tirzepatide achieved up to 15.7% weight loss in participants with obesity or excess weight in an 18-month trial. The research also revealed patients who took Tirzepatide showed a significant improvement in their blood sugar, cholesterol, and blood pressure levels.

It is important to keep in mind that weight loss can take time, and you’ll see the best results when you are using your medication in combination with a healthy diet, exercise, and the support of a health coach.

What can I expect from Forum Health’s Medical Weight Loss Program with Tirzepatide?

We offer a comprehensive 8-week, medically supervised weight loss program that is practitioner-led and supported by our expert health coach to maximize your results. You’ll first come in for an initial weight loss consultation to understand your unique challenges and needs. From there, we’ll develop a plan and prescription for you.

  • Fat loss without losing muscle mass
  • No-high intensity workouts
  • No insurance needed
  • Weight loss without surgery
  • No restrictive diets or calorie counting
  • No stimulant weight loss pill side effects

How is Forum Health’s Medical Weight Loss Program different?

There are many online pharmacies prescribing weight loss peptides without the support and root-cause approach to care that you need to truly succeed. Here are a few ways our program is different from what you might find elsewhere.

  • Precision Dosing – tailoring your prescription to your individual goals and needs.
  • Safe sourcing – dispensed from certified pharmacies
  • Upfront pricing – no hidden fees or upcharges
  • Increased success with accountability health coaching
  • Nutrition and lifestyle support for long-term results
  • Expert, licensed functional and integrative medical providers

Ready to start losing weight and feeling great?

Contact us today

https://www.nejm.org/doi/full/10.1056/NEJMoa2206038

Share:

Facebook
Twitter
LinkedIn
Categories